Raymond James Financial’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55M Buy
695,745
+359,259
+107% +$30.5M 0.01% 889
2026
Q1
$28.6M Sell
336,486
-78,124
-19% -$7.01M 0.01% 1223
2025
Q4
$36.3M Sell
414,610
-63,739
-13% -$4.84M 0.01% 1019
2025
Q3
$27.4M Sell
478,349
-204,944
-30% -$11.8M 0.01% 1200
2025
Q2
$40.3M Sell
683,293
-38,471
-5% -$2.49M 0.01% 892
2025
Q1
$52.8M Buy
721,764
+15,616
+2% +$1.29M 0.02% 696
2024
Q4
$58.4M Buy
+706,148
New +$55.7M 0.02% 645

Other funds holding GMED

Raymond James Financial's GMED Position: Q2 2026 in Review

Raymond James Financial increased its Globus Medical (GMED) stake by 107% in Q2 2026, buying an estimated $30.5M and bringing the position to 695,745 shares worth $55M. The position accounts for 0.01% of the portfolio, ranked #889.

Raymond James Financial first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $58.4M in Q4 2024. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Raymond James Financial held 695,745 shares of Globus Medical worth $55M as of Q2 2026.
  • Raymond James Financial bought 359,259 Globus Medical shares in Q2 2026, an estimated $30.5M.
  • Globus Medical made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #889 holding.
  • Raymond James Financial first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Globus Medical position peaked at $58.4M in Q4 2024.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.